Here are five executive moves announced in the spine and orthopedic device industry in the past month:
Preston Wells, vice president of financial planning and analysis at Stryker, will assume the role of vice president of investor relations, effective June 1. Previously, Mr. Wells served as finance director for DePuy Orthopaedics and senior finance director for Johnson & Johnson.
NanoFUSE Biologics, a subsidiary of KICVentures, appointed Jake Lubinski as CEO. Mr. Lubinski has served in several executive leadership roles within KICVentures portfolio companies, spearheading operational, business development and growth and acquisition initiatives.
Ken Yamada was appointed president and CEO of AxioMed, a spine device and subsidiary of private investment holding company KICVentures. Mr. Yamada was pivotal in the commercialization of LDR's Mobi-C cervical disc, which Zimmer Biomet acquired for $1.1 billion in 2016.
CurvaFix, a developer of implants to repair curved bone fractures, appointed Trevor Moody and Jeffrey Rydin to its board of directors. Mr. Rydin is past-president of global sales for NuVasive, while Mr. Moody co-led the medical device team at Frazier Healthcare Ventures, a private equity firm with more than $2 billion under management.
Biomaterial company Sintx Technologies' appointed orthopedic surgeon Mark Froimson, MD, to its board of directors. Dr. Froimson served on the faculty of the department of orthopedic surgery at the Cleveland Clinic for 16 years, where he held several leadership positions.